Open AccessThe relationship between pharmacy licensing policies on clinical training (CT) and success rates for international pharmacists (IPs) within Canada, United Kingdom, and the United States: A comparative policy analysis
Author(s) -
Amad Al-Azzawi
Publication year - 2021
Publication title -
pharmacy education
Language(s) - English
Resource type - Journals
SCImago Journal Rank - 0.198
H-Index - 17
eISSN - 1477-2701
pISSN - 1560-2214
DOI - 10.46542/pe.2021.211.420431
Subject(s) - pharmacy , legislation , license , licensure , clinical pharmacy , political science , medicine , family medicine , business , medical education , law
In October 2018, the Pharmacy Examining Board of Canada released a report showing that only 41.1% of international pharmacists pass the Pharmacy Qualifying Examination, compared to 91% of Canadian graduates. When compared to the United Kingdom and United States, Canada has the lowest success rates for the integration of international pharmacists. Aim: This study aims to address two questions: What are the professional pharmacy policies governing the clinical training resources for international pharmacists within their host country? What can Canada learn from other Western countries to facilitate the integration of international pharmacists? Method: A comparative policy analysis was used to draw comparisons between Canada’s regulatory policies governing the pharmacy license to other similar models in the United Kingdom and United States. Results: Upon examining current integration systems in these countries, differences in training period requirements and competencies became apparent. Therefore, the findings suggest that Canadian stakeholders can learn from other models’ legislation, structure, and clinical outcome prospects.